This Article Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by NEVILLE, W. E. Articles by PEACOCK, H. Search for Related Content PubMed Articles by NEVILLE, W. E. Articles by PEACOCK, H.

(Circulation. 1965;31:I-130.)
© 1965 American Heart Association, Inc.

---

Cardiopulmonary Bypass with Large Volume Nonblood Perfusate

Experimental and Clinical Observations

WILLIAM E. NEVILLE M.D.¹; LEON SCICCHITANO M.D.¹; HAYWARD MABEN M.D.¹; FEDOR BANUCHI M.D.¹; HOWARD PEACOCK B.T.¹

¹ From the Cardiopulmonary Surgery Section, Hines Veterans Administration Hospital, Hines, Illinois.

Experimental and clinical data have been presented which support the efficacy of using a large-volume nonblood perfusate for cardiopulmonary bypass. Dogs have consistently survived hemodilution of 100 to 120 ml/kg body wt when manifest hypoxic acidosis has been ameliorated with THAM (tris [hydroxymethyl] aminomethane) or sodium bicarbonate.

Fifty-eight patients have undergone total bypass with the disc oxygenator totally primed with 2,500 to 3,000 ml of buffered Ringer's or Ringer's lactate solution. Normothermia and moderate hypothermia have been employed with a hemodilution of 33 to 60 ml/kg body wt and a mean perfusion hematocrit of 24%. Despite the decrease in oxygen-carrying capacity of the blood, acidosis has not been observed during prolonged perfusions at median flow rates. Following oxygenator reinfusion, the postoperative total blood volume has been normal. However, a decrease in red cell mass was observed which necessitated the administration of "packed red cells." With this technique, the clotting time was more readily restored to normal, and kidney function was markedly improved over a comparable series of patients perfused with donor blood.